ClearPoint Neuro | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.50%)
ClearPoint Neuro | SC 13G/A:超過5%持股股東披露文件(修正)
ClearPoint Neuro | 8-K:重大事件
ClearPoint Neuro | 424B5:募資說明書
ClearPoint Neuro | 10-Q:季度報表
ClearPoint Neuro | 8-K:ClearPoint Neuro公佈2024年第三季度業績
ClearPoint Neuro | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.50%)
ClearPoint Neuro | 4:持股變動聲明-高管 SABRA MAZIN
ClearPoint Neuro | 4:持股變動聲明-董事 Girin Pascal E R
ClearPoint Neuro | 4:持股變動聲明-董事 Richards Timothy T.
ClearPoint Neuro | 4:持股變動聲明-董事 LIAU LINDA M.
ClearPoint Neuro | 4:持股變動聲明-董事 FLETCHER R JOHN
ClearPoint Neuro | SC 13D/A:超過5%持股股東披露文件(修正)-PTC Therapeutics, Inc.(3.24%)
ClearPoint Neuro | 8-K:重大事件
ClearPoint Neuro | 4:持股變動聲明-高管 STIGALL L. JEREMY
ClearPoint Neuro | 4:持股變動聲明-高管 D'Alessandro Danilo
ClearPoint Neuro | 4:持股變動聲明-高管 BURNETT JOSEPH MICHAEL
ClearPoint Neuro | 10-Q:2024財年二季報
ClearPoint Neuro | 8-K:ClearPoint Neuro公佈2024年第二季度業績
ClearPoint Neuro | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(1.3%)
暫無數據
暫無數據